Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7390 p256
4 March 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


GTN metabolism examined

Some Chinese individuals do not respond well to glyceryl trinitrate (GTN) because of a gene mutation present in 30 to 50 per cent of this population. The affected gene gives rise to a faulty version of the enzyme mitochondrial aldehyde dehydrogenase-2, which is responsible for converting GTN to its active form, nitric oxide (Journal of Clinical Investigation 2006;116:506).

Back to Top


©The Pharmaceutical Journal